Radiocontrast nephropathy: the dye is not cast.
A significant source of morbidity and inhospital mortality following percutaneous coronary intervention is radiocontrast-induced nephropathy. Newer strategies, such as using low-osmolar nonionic contrast agents and selective dopamine agonists, are making it possible to greatly reduce the incidence of postcatheterization nephropathy.
Lepor
N E
NE
Cedars-Sinai Medical Center, Los Angeles, California, USA.
D058186:Acute Kidney Injury / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D006328:Cardiac Catheterization; D003287:Contrast Media / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D018491:Dopamine Agonists / Q000627:therapeutic use; D018818:Fenoldopam / Q000627:therapeutic use; D006801:Humans; D019275:Radiopharmaceuticals / Q000009:adverse effects*; D012307:Risk Factors
D003287:Contrast Media; D018491:Dopamine Agonists; D019275:Radiopharmaceuticals; D003404:Creatinine; D018818:Fenoldopam